Salivary Tumor Types/Patterns Favored Age Gender Presentation Capsule Frequency/ Treatment

Gland Presence Prognosis

Pleomorphic Adenoma Nests, Sheets, Ducts, or Parotid 4th 6th F:M Slow-Growing, No True The most common Complete
Trabeculae (Epithelial Cells) (70% of its decade 3:1 Painless Mass Capsule of all salivary tumors Surgical
Myxoid, Chondroid, Fibroid, tumors) or Excision
or Osteoid (Stroma) 4:1 Facial Nerve
Preservation
Warthin's Tumor Parotid Older Males Slow-Growing, Encapsulated Recurrence &
(Papillary Cystadenoma (6-10% of its Caucasian Painless Mass Malignant
Lymphomatosum) tumors) Transformation are
RARE
3% associated
neoplasms
Benign Tumors

Oncocytoma Parotid 6th decade F:M Enlarging, Encapsulated Rare (2.3% of

(Mitochondrial (78%) 1:1 Pianless Mass benign salivary
Hyperplasia) Submandi- Mitochondrial tumors)
bular (9%) Hyperplasia
Monomorphic Adenomas 1- Basal Cell Adenoma Parotid 6th deca- F:M Painless Freely BCA is the most
Solid(most common) (BCA) de (BCA) 1:1 Movable common between
Trabicular Minor Caucasian (BCA) Submucosal benign epithelial
Tubular Glands 1.8 : 1 Mass (CA) salivary tumors
Membranous (Upper Lip) 7th deca- (CA)
2- Canalicular Adenoma de (CA)
3- Sebaceous Adenoma
4- Glycogen-Rich Aden.
5- Clear Cell Adenoma
Myoepithelioma Histologically: Parotid> 3rd 6th Females Asymptomatic <1% of all salivary
1- Spindle Cell (70%) Minor decade Mass tumors
2- Plasmacytoid (20%) Glands> Prognosis is
3- Both (10%) Submandi- excellent, recurrence
bular not expected
Mucoepidermoid Parotid (45- 3rd 8th Females Low-Grade: Encapsulated The most common Stage I, II:
Carcinoma 70%) decade Slow-Growing Or: malignant salivary WLE
Palate (18%) Caucasian Painless Mass Partially tumors Stage III, IV:
High-Grade: Or: Not 5-9% of Salivary Radical E.
Malignant Tumors

Enlarging, +/- Encapsulated Neoplasm +/- N. D.

Pain +/- P.O. XRT
Adenoid Cystic Minor Glands 5th decade F:M Enlarging Mass Recurrence 42% Facial Nerve
Carcinoma (Palate) 1:1 Pain is common Metastasis to Lungs Sacrifice
Acinic Cell Carcinoma Parotid 5th decade Females Slow-Growing, Complete L.E
Painless Mass +/- P.O. XRT
Adenocarcinoma Parotid & 5th 8th Females Enlarging Mass L. Recurrence 51% Complete L.E
Minor Salivary decade 25% Pain, F.W. R. Metastasis 27% N. D.
Glands D. Metastasis 26% P.O. XRT
Malignant Mixed Tumors 1- Carcinoma Ex- Parotid> 6th 8th Painless Mass, 2-4% of all S. tumors Radical E
Pleomorphic Adenoma Submandi- decade Sudden 4-6% of mixed tumor N. D.
2- Carcinasarcoma bular> Enlargement (C. Ex-P. A.) P.O. XRT
3- Metastatic Mixed Tumors Palate